Viral Clearance Market Size to Reach USD 1,967.68 Million in 2028; CAGR of 21.9%: Reports and Data

New York, New York--(Newsfile Corp. - April 22, 2021) - Increasing need for complete viral safety, growing demand for highly pure biotherapeutics, and rising investment in pharmaceutical and biotechnology sector are key factors expected to drive market growth.

Market Size - USD 403.5 Million in 2020, Market Growth - at a CAGR of 21.9%, Market Trends - Rapid technological advancements in viral clearance techniques

The global viral clearance market size is expected to reach USD 1,967.68 Million in 2028 at a CAGR of 21.9%, according to a latest report by Reports and Data. Increasing demand for monoclonal antibodies and therapeutics, rising drug approvals, and growing investment in R&D activities in biotechnology and pharmaceutical sector are key factors expected to drive market revenue growth over the forecast period. Virus removal and inactivation are crucial in overall bioprocess safety, and growing expenditure in R&D to develop efficient viral clearance validation studies to ensure safety of drugs and other biologics is also expected to drive market revenue growth over the forecast period.

Viral contamination is a major problem of all human and animal-based biopharmaceutical processes. Recombinant protein therapeutics, blood and blood derived products, cell-based therapeutic proteins, and vaccines are highly susceptible to viral contamination. This increases need for viral safety that involves downstream viral clearance tasks that remove or inactivate potential viral contaminants. Various methods are used to test and detect harmful viruses in biologics that include in vitro methods such as cell density testing and polymerase chain reaction (PCR) testing. The advent of Next-Generation Sequencing (NGS) is expected to provide rapid and accurate detection of contaminating viruses. Increasing use of this technique is expected to contribute significantly to revenue growth of the market over the forecast period. Implementation of preventive measures such as virus-retentive filtration by biotechnology and pharmaceutical companies to prevent viral contamination is also expected to further fuel revenue growth of the market over the forecast period.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/4001

Viral clearance is imperative in the process development of monoclonal antibodies, glycoproteins, tissue-based products, plasma products, and gene-based therapeutic products. Viral clearance studies are also important prior to entering clinical trials and for commercialization of biopharmaceuticals and this has led to further developments in phase-appropriate viral clearance validation processes. This is expected to further contribute significantly to revenue growth of the market over the forecast period. However, lack of skilled professionals, high costs associated with the process, and time-intensive drug development process are key factors expected to hamper market growth to a certain extent over the forecast period.

Some Key Highlights From the Report:

• Viral removal method segment is expected to account for significant revenue share in the global market owing to increasing adoption of this method, growing investment in R&D activities, and key attributes of this method such as increased accuracy, speed, and flexibility that are driving preference. In addition, rapid advancements and upgrades in nanofiltration technology is also expected to boost revenue growth of this segment.
• Increasing awareness regarding stem cell therapies, rising application of tissue-based therapies for treatment of various chronic illnesses, and growing public and private investment in stem cell research are key factors boosting revenue growth of other applications segments.
• Contract Research Organizations (CROs) segment is expected to account for considerable revenue share in the global market over the forecast period owing to increasing penetration of CROs worldwide, rising investment in advanced drug discovery platforms by researchers, and increasing trend of outsourcing drug development by pharma and biotech companies to CROs.
• Asia Pacific is expected to register robust revenue CAGR over the forecast period owing to increasing number of CROs in APAC countries such as China, India, and Japan, rising funding by pharmaceutical and biotechnology companies, increasing demand for biologics and therapeutics due to growing healthcare burden due to rising prevalence of chronic diseases, and increasing development of generic drugs in countries in the region.
• Prominent players operating in the global market include Charles River Laboratories International, Inc., WuXi Biologics, Lonza Group, Merck KGaA, Sigma-Aldrich Corporation, Avance Biosciences Inc., BSL BIOSERVICE, Clean Cells, SGS S.A., Texcell, Inc., and Vironova Biosafety.
• In January 2021, Mountain Valley MD Holdings signed an agreement to conduct its Bio safety Level 4 lab study to examine coronavirus viral clearance in transgenic mice. The study has been designed with the purpose of ensuring superiority of solubilized Ivermectin technology of the company as compared to the oral form available in the market in terms of speed and efficiency of viral clearance.

Order Now: https://www.reportsanddata.com/checkout-form/4001

For the purpose of this report, Reports and Data has segmented the global viral clearance market based on method, application, end-use, and region:

Method Outlook (Revenue, USD Million; 2018-2028)

• Viral Removal
  • Chromatography
  • Nanofiltration
  • Precipitation
• Viral Inactivation
  • Low pH
  • Solvent Detergent Method
  • Pasteurization
  • Other Viral Inactivation Methods
• Viral Detection

Application Outlook (Revenue, USD Million; 2018-2028)

• Recombinant Proteins
• Blood and Blood Products
• Vaccines
• Other Applications

End-use Outlook (Revenue, USD Million; 2018-2028)

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Others

Regional Outlook (Revenue, USD Million; 2018-2028)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • Italy
  • France
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East & Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Rest of MEA

Brower Similar reports of Pharmaceutical Industry:

Rheometers and Viscometers Market Size, Share & Analysis, By Product Type (Dynamic Rotational Rheometers, Torque Rotational Rheometers, Oscillatory Rheometers, Capillary Rheometers, Capillary Viscometers, Rotational Viscometers, Process Viscometers, Others), By Sample Type (Resins & Coatings, Suspensions & Slurries, Pastes & Gels, Others), By End-User (Pharmaceutical, Biotechnology, And Cosmeceutical Companies, Petroleum Product Manufacturers & Petrochemical Refineries, Food And Beverage Manufacturers, Others), And By Region Forecast To 2028

Immuno-oncology Market Size, Share & Analysis, By Treatment Type (Antibodies, Vaccines, Checkpoint Inhibitors), By Cancer Type (Melanoma, Renal Cell Cancer, Prostate Cancer, Lung Cancer, Blood Cancer, Bladder Cancer), By End-User (Clinics, Hospitals, Cancer Research Institutes), And By Region, Forecast To 2028

Dual Chamber Prefilled Syringes Market Size, Share & Analysis, By Material (Glass And Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, And Diabetes), Product (Liquid/Powder, Liquid/Liquid), And Region - Global Forecast To 2028

Rabies Monoclonal Antibody Market Size, Share & Analysis, By Product Type (Category II Exposure, Category III Exposure), By Application (Adult, Children), And By Region, Forecast To 2028

Cinitapride Market Size, Share & Analysis, By Dosage Type (1 mg, 3 mg), By Distribution Channel (Offline, Online), and By Region, Forecast To 2028

Injectable Sumatriptan Market Size, Share & Analysis, By Dosage Type (4 Mg, 6 Mg, Others), By End-User (Hospitals, Clinics, Others), And By Region, Forecast To 2028

Brain Health Supplements Market Size, Share & Analysis, By Product (Herbal Extract, Vitamins And Minerals, Natural Molecules), By Application (Memory Enhancement, Anxiety, Mood And Depression, Longevity And Anti-Aging, Sleep And Recovery, And Attention And Focus), By Supplement Type (Tablets, Capsules), By Age Group (Children, Adults, And Elderly), By Sales Channel (Supermarkets, Pharmacies, And Drug Stores, Online, And Others), Region And Forecast To 2028

Plasma Expander Market Size, Share & Analysis, By Type (Dextran, Hydroxyethyl Starch, Human Albumin, PEGylated Albumin, Polyvinylpyrrolidone (PVP), Gelatin), By Sales Channel (Online Pharmacies, Retail Pharmacies, And Hospital Pharmacies), And By Region, Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W
Head of Business Development
Reports And Data
Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-viral-clearance-market

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81429